Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
4.530
+0.460 (11.30%)
At close: Jul 1, 2026, 4:00 PM EDT
4.650
+0.120 (2.65%)
After-hours: Jul 1, 2026, 5:07 PM EDT
Kalaris Therapeutics Market Cap
Kalaris Therapeutics has a market cap or net worth of $107.78 million as of July 1, 2026. Its market cap has increased by 115.84% in one year.
Market Cap
107.78M
Enterprise Value
5.03M
1-Year Change
115.84%
Ranking
Category
Stock Price
$4.53
Market Cap Chart
Since March 19, 2025, Kalaris Therapeutics's market cap has decreased from $214.52M to $107.78M, a decrease of -49.76%. That is a compound annual growth rate of -41.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 107.78M | -31.72% |
| Dec 31, 2025 | 157.85M | -26.42% |
| Mar 19, 2025 | 214.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atara Biotherapeutics | 100.64M |
| Biomea Fusion | 100.50M |
| Black Diamond Therapeutics | 100.28M |
| OS Therapies | 99.77M |
| Lixte Biotechnology Holdings | 99.56M |
| Alps Group | 98.18M |
| Fortress Biotech | 98.00M |
| Cognition Therapeutics | 97.55M |